Picture of Heidelberg Pharma AG logo

HPHA — Heidelberg Pharma AG News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Brief: Heidelberg Pharma 9-month Sales Up 2 Pct To EUR 1.7 Billion

Feb 7 (Reuters) - Heidelberg Pharma AG  WL6G.DE :
    * NINE-MONTH SALES OF EUR1,693 MILLION APPROXIMATELY 2
PERCENT UP
ON PREVIOUS YEAR
    * TARGETS FOR FINANCIAL YEAR 2018/2019 AS A WHOLE STILL IN
SIGHT
    * AT EUR101 MILLION,9MTH  EBITDA EXCLUDING RESTRUCTURING
RESULT
DID NOT QUITE REACH PREVIOUS YEAR'S FIGURE OF EUR105
    * 9MTH EBIT EXCLUDING RESTRUCTURING RESULT TOTALED EUR49
MILLION
(PREVIOUS YEAR: EUR54 MILLION)


Further company coverage:  WL6G.DE 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Heidelberg Pharma AG

See all news